RAC 2.92% $1.94 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-33

  1. 3,262 Posts.
    lightbulb Created with Sketch. 345
    Do you think this promotional interview will help to attract more shareholders?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.